In addition, Lin et al. found in vivo and in vitro experiments that the absence of cysteine desulfurase (NFS1) synergistically interacted with oxaliplatin treatment could increase the intracellular reactive oxygen species level to trigger PANoptosis, thus significantly enhancing the sensitivity of CRC cells to oxaliplatin. The gene discussed is NFS1; the disease is colorectal carcinoma.